Literature DB >> 30219309

Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Alexandra I Wells1, Carolyn B Coyne2.   

Abstract

Barrier surfaces such as the epithelium lining the respiratory and gastrointestinal (GI) tracts, the endothelium comprising the blood-brain barrier (BBB), and placental trophoblasts provide key physical and immunological protection against viruses. These barriers utilize nonredundant mechanisms to suppress viral infections including the production of interferons (IFNs), which induce a strong antiviral state following receptor binding. However, whereas type I IFNs control infection systemically, type III IFNs (IFN-λs) control infection locally at barrier surfaces and are often preferentially induced by these cells. In this review we focus on the role of IFN-λ at barrier surfaces, focusing on the respiratory and GI tracts, the BBB, and the placenta, and on how these IFNs act to suppress viral infections.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  barrier surfaces; innate immunity; interferon; placenta

Mesh:

Substances:

Year:  2018        PMID: 30219309      PMCID: PMC6179363          DOI: 10.1016/j.it.2018.08.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  74 in total

Review 1.  Structure and function of the blood-brain barrier.

Authors:  N Joan Abbott; Adjanie A K Patabendige; Diana E M Dolman; Siti R Yusof; David J Begley
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

2.  Organotypic models of type III interferon-mediated protection from Zika virus infections at the maternal-fetal interface.

Authors:  Jacqueline Corry; Nitin Arora; Charles A Good; Yoel Sadovsky; Carolyn B Coyne
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

3.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

4.  Characterization of the type I interferon locus and identification of novel genes.

Authors:  Matthew P Hardy; Catherine M Owczarek; Lars S Jermiin; Mikael Ejdebäck; Paul J Hertzog
Journal:  Genomics       Date:  2004-08       Impact factor: 5.736

5.  Human placental trophoblasts confer viral resistance to recipient cells.

Authors:  Elizabeth Delorme-Axford; Rogier B Donker; Jean-Francois Mouillet; Tianjiao Chu; Avraham Bayer; Yingshi Ouyang; Tianyi Wang; Donna B Stolz; Saumendra N Sarkar; Adrian E Morelli; Yoel Sadovsky; Carolyn B Coyne
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

6.  Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.

Authors:  Christopher R Bolen; Siyuan Ding; Michael D Robek; Steven H Kleinstein
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

Review 7.  Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System.

Authors:  Brian P Daniels; Robyn S Klein
Journal:  PLoS Pathog       Date:  2015-09-17       Impact factor: 6.823

Review 8.  Airway Epithelial Cell Cilia and Obstructive Lung Disease.

Authors:  Asma Yaghi; Myrna B Dolovich
Journal:  Cells       Date:  2016-11-11       Impact factor: 6.600

9.  Identification of a Predominantly Interferon-λ-Induced Transcriptional Profile in Murine Intestinal Epithelial Cells.

Authors:  Tharini A Selvakumar; Sudeep Bhushal; Ulrich Kalinke; Dagmar Wirth; Hansjörg Hauser; Mario Köster; Mathias W Hornef
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

10.  Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses.

Authors:  Markus Mordstein; Georg Kochs; Laure Dumoutier; Jean-Christophe Renauld; Søren R Paludan; Kevin Klucher; Peter Staeheli
Journal:  PLoS Pathog       Date:  2008-09-12       Impact factor: 6.823

View more
  45 in total

1.  Interferon Lambda: An Immune System Factor That Cancer Epidemiologists Should Consider.

Authors:  Danielle Mercatante Carrick
Journal:  J Interferon Cytokine Res       Date:  2019-03-20       Impact factor: 2.607

2.  Innate IFN-lambda responses to dsRNA in the human infant airway epithelium and clinical regulatory factors during viral respiratory infections in early life.

Authors:  Kyle Salka; Maria Arroyo; Elizabeth Chorvinsky; Karima Abutaleb; Geovanny F Perez; Seth Wolf; Xilei Xuchen; Jered Weinstock; Maria J Gutierrez; Marcos Pérez-Losada; Dinesh K Pillai; Gustavo Nino
Journal:  Clin Exp Allergy       Date:  2020-07-26       Impact factor: 5.018

3.  Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1.

Authors:  Alessandra Pierangeli; Agnese Viscido; Camilla Bitossi; Federica Frasca; Massimo Gentile; Giuseppe Oliveto; Antonella Frassanito; Raffaella Nenna; Fabio Midulla; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2019-09-04       Impact factor: 3.402

Review 4.  Shared and Distinct Functions of Type I and Type III Interferons.

Authors:  Helen M Lazear; John W Schoggins; Michael S Diamond
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

5.  Aminopeptidase N Expression, Not Interferon Responses, Determines the Intestinal Segmental Tropism of Porcine Deltacoronavirus.

Authors:  Lingdan Yin; Jianfei Chen; Liang Li; Shanshan Guo; Mei Xue; Jialin Zhang; Xiang Liu; Li Feng; Pinghuang Liu
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

Review 6.  Interferon-λ orchestrates innate and adaptive mucosal immune responses.

Authors:  Liang Ye; Daniel Schnepf; Peter Staeheli
Journal:  Nat Rev Immunol       Date:  2019-06-14       Impact factor: 53.106

7.  Selective Janus kinase inhibition preserves interferon-λ-mediated antiviral responses.

Authors:  Daniel Schnepf; Stefania Crotta; Thiprampai Thamamongood; Megan Stanifer; Laura Polcik; Annette Ohnemus; Juliane Vier; Celia Jakob; Miriam Llorian; Hans Henrik Gad; Rune Hartmann; Birgit Strobl; Susanne Kirschnek; Steeve Boulant; Martin Schwemmle; Andreas Wack; Peter Staeheli
Journal:  Sci Immunol       Date:  2021-05-14

Review 8.  Herpesviruses and the Type III Interferon System.

Authors:  Yue Yin; Herman W Favoreel
Journal:  Virol Sin       Date:  2021-01-05       Impact factor: 4.327

9.  Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in South African women.

Authors:  Charlene Akoto; Shane A Norris; Joris Hemelaar
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

10.  Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant women.

Authors:  A Lapolla; M G Dalfrà; S Burlina
Journal:  Acta Diabetol       Date:  2021-06-28       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.